A statin-dependent QTL for GATM expression is associated with statin-induced myopathy.

A statin-dependent QTL for GATM expression is associated with statin-induced myopathy.

Show other versions (1)

Statins are prescribed widely to lower plasma low-density lipoprotein (LDL) concentrations and cardiovascular disease risk and have been shown to have beneficial effects in a broad range of patients. However, statins are associated with an increased risk, albeit small, of clinical myopathy and type...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Mangravite, L, Engelhardt, B, Medina, M, Smith, J, Brown, C, Chasman, D, Mecham, B, Howie, B, Shim, H, Naidoo, D, Feng, Q, Rieder, M, Chen, Y, Rotter, J, Ridker, P, Hopewell, J, Parish, S, Armitage, J, Collins, R, Wilke, R, Nickerson, D, Stephens, M, Krauss, R
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2013

Eitemau Tebyg

A statin-dependent QTL for GATM expression is associated with statin-induced myopathy
gan: Mangravite, L, et al.
Cyhoeddwyd: (2013)

Statin-Induced Myopathy
gan: D. A. Sychev, et al.
Cyhoeddwyd: (2023-09-01)

SLCO1B1 variants and statin-induced myopathy--a genomewide study.
gan: Link, E, et al.
Cyhoeddwyd: (2008)

Genetic variation in lipid response to statin therapy in 18,705 participants in the heart protection study
gan: Hopewell, J, et al.
Cyhoeddwyd: (2011)

Myopathy associated with statin therapy.
gan: Hilton-Jones, D
Cyhoeddwyd: (2008)

STATINS AND MYOPATHY: MOLECULAR MECHANISMS
gan: O. M. Drapkina, et al.
Cyhoeddwyd: (2015-12-01)

STATINS AND MYOPATHY: MOLECULAR MECHANISMS
gan: O. M. Drapkina, et al.
Cyhoeddwyd: (2015-12-01)

No Impact of KIF6 Genotype on Vascular Risk or Statin Benefit in the Heart Protection Study
gan: Hopewell, J, et al.
Cyhoeddwyd: (2009)

STATINS, MYOPATHY AND PHYSICAL ACTIVITY
gan: Elena SÎRBU, et al.
Cyhoeddwyd: (2018-12-01)

Are statins anti-inflammatory?
gan: Ridker Paul M, et al.
Cyhoeddwyd: (2000-11-01)

MYOPATHY CAUSED BY THE INTERACTION OF COLCHICINE AND STATINS
gan: A. S. Kazakov, et al.
Cyhoeddwyd: (2018-09-01)

A Mechanism for Statin-Induced Susceptibility to Myopathy
gan: Sabine Lotteau, PhD, et al.
Cyhoeddwyd: (2019-08-01)

Impact of vitamin D status on statin-induced myopathy
gan: Krista D. Riche, Pharm.D., et al.
Cyhoeddwyd: (2016-12-01)

The Impact of Exercise on Statin-Associated Skeletal Muscle Myopathy.
gan: Hae R Chung, et al.
Cyhoeddwyd: (2016-01-01)

Statins and Immune-Mediated Necrotizing Myopathy
gan: Mauro Turrin
Cyhoeddwyd: (2018-10-01)

Statin-Induced Necrotizing Autoimmune Myopathy
gan: Brent Gawey, BS, et al.
Cyhoeddwyd: (2020-03-01)

Statin-Induced Autoimmune Necrotizing Myopathy
gan: Sahani Jayatilaka, et al.
Cyhoeddwyd: (2021-07-01)

Statin therapy, myopathy and exercise--a case report
gan: Semple Stuart J
Cyhoeddwyd: (2012-03-01)

Autoimmune statin-induced myopathy: a case report
gan: Jonathan B. Young, et al.
Cyhoeddwyd: (2015-09-01)

APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY
gan: D. A. Sychev, et al.
Cyhoeddwyd: (2015-09-01)

APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY
gan: D. A. Sychev, et al.
Cyhoeddwyd: (2015-09-01)

Pharmacogenomics of statin therapy: any new insights in efficacy or safety?
gan: Hopewell, J, et al.
Cyhoeddwyd: (2014)

A multivariate genome-wide association analysis of 10 LDL subfractions, and their response to statin treatment, in 1868 Caucasians.
gan: Heejung Shim, et al.
Cyhoeddwyd: (2015-01-01)

GWAS of CRP response to statins further supports the role of APOE in statin response: A GIST consortium study
gan: Emma F. Magavern, et al.
Cyhoeddwyd: (2025-02-01)

No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study.
gan: Hopewell, J, et al.
Cyhoeddwyd: (2011)

Misrepresentation of statin safety evidence.
gan: Armitage, J, et al.
Cyhoeddwyd: (2014)

Genome-wide association of statin-induced myopathy
gan: Link, E
Cyhoeddwyd: (2009)

Challenges in Treating Statin-Associated Necrotizing Myopathy
gan: Patrick Webster, et al.
Cyhoeddwyd: (2021-01-01)

New experimental possibilities for statin myopathy diagnosing
gan: E. V. Vinogradova, et al.
Cyhoeddwyd: (2021-07-01)

Statin-Associated Autoimmune Myopathy: Current Perspectives
gan: Tiniakou E
Cyhoeddwyd: (2020-05-01)

Creatine as a Candidate to Prevent Statin Myopathy
gan: Maurizio Balestrino, et al.
Cyhoeddwyd: (2019-09-01)

The safety of statins in clinical practice.
gan: Armitage, J
Cyhoeddwyd: (2007)

Statin-induced necrotizing autoimmune myopathy: an extremely rare adverse effect from statin use
gan: Priyadarshani Sharma, et al.
Cyhoeddwyd: (2019-11-01)

Statin Cost-Effectiveness in the United States for People at Different Vascular Risk Levels
gan: Mihaylova, B, et al.
Cyhoeddwyd: (2009)

Glycine amidinotransferase (GATM), renal Fanconi syndrome, and kidney failure
gan: Reichold, M, et al.
Cyhoeddwyd: (2018)

GATM, the human ortholog of the mouse imprinted Gatm gene, escapes genomic imprinting in placenta
gan: Toshinobu Miyamoto, et al.
Cyhoeddwyd: (2005-03-01)

Statin-associated necrotizing myopathy: a rare etiology
gan: Catarina Ferreira Moita, et al.
Cyhoeddwyd: (2020-12-01)

The role of Coenzyme Q10 in statin-associated myopathy
gan: Sanjay Kalra, et al.
Cyhoeddwyd: (2009-10-01)

Phenotype standardization for statin-induced myotoxicity.
gan: Alfirevic, A, et al.
Cyhoeddwyd: (2014)

Interpretation of the evidence for the efficacy and safety of statin therapy
gan: Collins, R, et al.
Cyhoeddwyd: (2016)